OLD Category: Oncology

Increased breast tissue receptor activator of nuclear factor- κB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women

• Toriola AT, et al.

Expression of Cathepsins B, D, and G in Isocitrate Dehydrogenase-Wildtype Glioblastoma

• Koh SP, et al.

Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism

• De Santi C, et al.

Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell function

• Singh N et al.,

Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors

• Pinto N, et al.

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population

• Gómez-Miragaya J, et al.

Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

• Prat A, Navarro A, Paré L, Reguart N, Victoria I , Viñolas N, Vivancos A, Arance A, Felip E

In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies

• Pinto J, et al.

T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas

• Pollack S.M. et al.,

miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesothelioma

• Mairinger FD, et al.

MiR-200b and miR-155 as predictive biomarkers for the efficacy of chemoradiation in locally advanced head and neck squamous cell carcinoma

• Hess A.K. et al.,

Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression

• Fiziev P, et al.